SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹9.85 Cr | ₹39 Cr | ₹-1.09 Cr | ₹-0.66 Cr | ₹-0.21 Cr |
What is the latest Cash Flow from Financing Activities ratio of SHREE GANESH REMEDIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹9.85 Cr |
Mar2023 | ₹39 Cr |
Mar2022 | ₹-1.09 Cr |
Mar2021 | ₹-0.66 Cr |
Mar2020 | ₹-0.21 Cr |
How is Cash Flow from Financing Activities of SHREE GANESH REMEDIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹9.85 Cr | -74.52 | |
Mar2023 | ₹39 Cr | Positive | |
Mar2022 | ₹-1.09 Cr | Negative | |
Mar2021 | ₹-0.66 Cr | Negative | |
Mar2020 | ₹-0.21 Cr | - |
Compare Cash Flow from Financing Activities of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹1,017.0 Cr | -2.8% | 16.7% | 14.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | -2.8% |
16.7% |
14.5% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses